Help us: Donate
Follow us on:
×

Menu

Back

Aubrey de Grey: Aging Research in the Age of COVID-19

We talk with Dr. Aubrey de Grey about aging research progress during the pandemic.
Aubrey de Grey on COVID-19Aubrey de Grey on COVID-19

Dr. Aubrey de Grey is a biomedical gerontologist and the founder of the concept of strategies for engineered negligible (SENS), a strategy which breaks down the aging process into seven categories with proposed solutions to each. He is the Chief Science officer at the SENS Research Foundation, a non-profit dedicated to combating the aging process.

Dr. Aubrey de Grey is also the Editor-in-Chief of Rejuvenation Research, is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations.

In this interview, Brent Nally and Dr. Aubrey de Grey discuss the progress of aging research amid the current COVID-19 pandemic, along with the state of the industry’s leaders and major backers – and many other topics related to the science of making people young again.

We would like to thank Dr. Aubrey de Grey for taking the time out from his busy schedule to speak with us.

HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
Lifespan.io YouTube
Lifespan.io Facebook
Lifespan.io Twitter
Lifespan.io Instagram
Lifespan.io Instagram
Lifespan.io Discord
Thank You!

About the author

Brent Nally

Brent Nally is obsessed with solving the human aging problem. Brent interviews longevity experts and hosts Lifespan News. Brent is a CEO/co-founder of Longevity Plan. Brent is a proud father, husband, son, brother, entrepreneur, investor and loves improving reality.
No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.